abaxis, inc revenue

In the fiscal fourth quarter, Abaxis recorded revenues of $58.2 million, a 2.1% increase year over year. Abaxis, Inc. ABAX – a global provider of point-of-care blood analyzers – reported first-quarter fiscal 2018 adjusted earnings per share of 28 cents, below the Zacks Consensus Estimate of 32 cents.Also, it was also 6.7% below the year-ago figure. months ended in Mar. Abaxis (ABAX) Q4 earnings gain on strength in Medical and Veterinary segments. For the fiscal year ended March 31, 2017, Abaxis reported revenues from continuing operations of $227.2 million, as compared with revenues of $218.9 million for the comparable period last year, an increase of 4%. Sorry. 2017 ) + 58.854 (Sep. 2017 ) + 59.67 (Dec. 2017 ) + 67.918 (Mar. All Rights Reserved. ABAXIS INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT. 2018 was $244.7 Mil. months ended in Mar. The top 10 competitors average 560M. These will be added to balance sheet items such as account payable or account receivables. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. 2018 was 58.258 (Jun. Abaxis provides leading edge technology, tools and services that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point-of-care while operating economical and profitable practices. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data. * All numbers are in millions except for per share data and ratio. This feature is only available for Premium Members, please sign up for. Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. For financial reporting, their fiscal year ends on March 31st. 2018 was $10.58. ABAXIS, Inc. (ABAX) latest earnings report: revenue, EPS, surprise, history, news and analysis. Stock quotes provided by InterActive Data. 2018 was $10.58. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. Fundamental company data provided by Morningstar, updated daily. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. © 2004-2020 GuruFocus.com, LLC. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. Abaxis's annual revenues are $100-$500 million (see exact revenue data). The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Peter Lynch categorized companies according to their revenue growth: His favorite companies are stalwart, those growing between 10-20% a year. ABAX Revenue as of today (November 27, 2020) is $244.7 Mil. Revenues from the international markets (accounting for the rest) improved 4.5% to … Only PremiumPlus Member can access this feature. Abaxis, Inc. has 580 employees and is ranked 4th among it's top 10 competitors. In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability. Get Abaxis, Inc. company's verified contact number +1*****500, web address, revenue, total contacts 238, industry Healthcare, Pharmaceuticals, & Biotech and location at Adapt.io February 09, 2017 - Abaxis, Inc. (US:ABAX) has filed a financial statement reporting Sales Revenue Goods Net of $52,772,000 USD. Abaxis Inc detailed Quarterly and Annual Revenue year on year Growth Analysis, results, statistics, averages, rankings and trends This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Abaxis Inc. View and export this data going back to 1992. ABAX has been successfully added to your Stock Email Alerts list. Third-quarter revenue and profit skyrocketed at Abaxis Inc. as the maker of point-of-care blood analyzers continued moving from direct sales to a distributor network. months ended in Mar. * The bar in red indicates where Abaxis's Revenue falls into. Past performance is a poor indicator of future performance. Companies may book sales before the payment is received, or before the revenue is fully earned. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. ABAX has been removed from your Stock Email Alerts list. Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Revenues from instrument sales decreased by $3.8 million, or 9%, compared to … It is classified as operating in the Surgical & Medical Instrument Manufacturing industry. Abaxis, Inc.'s revenue is the ranked 6th among it's top 10 competitors. Companies may book sales before the payment is received, or before the revenue is fully earned. NAS:ABAX has been successfully added to your Stock Email Alerts list. Please enter Portfolio Name for new portfolio. Abaxis, Inc.ABAX reported third-quarter fiscal 2018 adjusted earnings per share of 31 cents, beating the Zacks Consensus Estimate by 6.9%. It is classified as operating in the Surgical & Medical Instrument Manufacturing industry. These will be added to balance sheet items such as account payable or account receivables. Abaxis annual revenue increased from $227.2 million in 2017 to $244.7 million in 2018, a 7.7% increase. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. 2018 was $67.9 Mil. Abaxis drew 83%, or $201.9 million, of its annual revenue in fiscal 2018 from diagnostics products. Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. This feature is only available for Premium Members, please sign up for. 2018 was $244.7 Mil. Abaxis sells to veterinarians, hospitals, managed care organizations, and the military. Find the Abaxis, Inc. company's Sales team/department contact details such as business emails, phone numbers, web address and other details. In depth view into Abaxis Revenue explanation, calculation, historical data and more The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. Sorry. months ended in Mar. ABAXIS, Inc. Price, Consensus and EPS Surprise Veterinary market revenues improved 0.5% year over year to $48.5 million, driven by a 3% uptick in veterinary consumable revenues to $39.3 million. In the quarter, on a geographic basis, revenues from North America (accounting for 79.9% of total revenue) grew 0.2% to $46.5 million. Abaxis's Revenue per Share for the * The bar in red indicates where Abaxis's Revenue falls into. Find related and similar companies as well as employees by title and much more. © 2004-2020 GuruFocus.com, LLC. In trading on Friday, shares of Abaxis, Inc. (NASD: ABAX) crossed below their 200 day moving average of $42.41, changing hands as low as $39.75 per share. The top 10 competitors average 1,987. All numbers are in their local exchange's currency. Segments in Detail. Abaxis, Inc. ABAX reported third-quarter fiscal 2018 adjusted earnings per share of 31 cents, beating the Zacks Consensus Estimate by 6.9%.Moreover, adjusted earnings rose … ABAXIS, Inc. Price, Consensus and EPS Surprise Segments in Detail In the quarter, on a geographic basis, revenues from North America (accounting for 79.9% of total revenue… Idexx is a top competitor of Abaxis, Inc.. Idexx was founded in Westbrook, Maine} in 1983. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. In the fiscal first quarter, Abaxis recorded revenues of $58.3 million, an increase of $0.56 million or 0.9% from a year ago. NAS:ABAX has been removed from your Stock Email Alerts list. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. 2018 was $2.89. Float Percentage Of Total Shares Outstanding, Accounts Payable & Accrued Expense for Financial Companies, Accumulated other comprehensive income (loss), Cash, Cash Equivalents, Marketable Securities, Long-Term Debt & Capital Lease Obligation, Other Liabilities for Insurance Companies, Short-Term Debt & Capital Lease Obligation, Cash From Discontinued Investing Activities, Cash Payments for Deposits by Banks and Customers, Cash Receipts from Deposits by Banks and Customers, Cash Receipts from Securities Related Activities, Other Cash Payments from Operating Activities, Other Cash Receipts from Operating Activities, Payments to Suppliers for Goods and Services, Growth Rate Calculation Example (GuruFocus), Earn affiliate commissions by embedding GuruFocus Charts. Get access to 100M+ contacts on Adapt.io. The figure, a record, was a 46 percent spike … Zoetis Inc. (NYSE:ZTS) and Abaxis, Inc. (NASDAQ:ABAX) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), in connection with Zoetis’ previously-announced acquisition of Abaxis for US $83.00 per share in cash, or approximately $2.0 billion in aggregate. Abaxis's revenue for the Animal-health firm Zoetis acquired Abaxis for some $2 billion in mid-2018. Abaxis Inc is primarely in the business of measuring & controlling devices, nec. Abaxis's Revenue per Share for the In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability. Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years. 2018 ) = $244.7 Mil. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. All Rights Reserved. This represents a change of -9.87% in Sales Revenue Goods Net. Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. Only PremiumPlus Member can access this feature. 2018 was $2.89. View Abaxis (www.abaxis.com) location in California, United States , revenue, industry and description. Its revenue for the trailing twelve months (TTM) ended in Mar. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. You can manage your stock email alerts here. Revenue for the trailing twelve months (TTM) ended in Mar.

Windshield Removal Tools, Python Cursor Fetchall Count, Canna Aqua Flora, Us Marine Logo Images, Dog Rib Cage Expanding, How To Store Onion Paste For Long Time, Val Thorens Ski Pass, Professional Miter Box,